Apimeds Pharmaceuticals US, Inc. Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

Apimeds Pharmaceuticals US, Inc. Share Price Chart

$0.00$0.00

Apimeds Pharmaceuticals US, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2025	Jun 2025	Sep 2025
Revenue	N/A	N/A	N/A
Net Profit	-$402397.00	-$2.66M	-$1.78M
Net Profit Margin	N/A	N/A	N/A
Income Change	N/A	-561.58%	33.09%

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, a purified, pharmaceutical grade venom of the Apis mellifera, or honeybee for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey.

Apimeds Pharmaceuticals US, Inc. Historical Returns

Month	Open	Close	Change %

APUS Share Price FAQs

What is Apimeds Pharmaceuticals US, Inc. share price today?

Apimeds Pharmaceuticals US, Inc. share price today is $0.00 as on August 9, 2026 at 10:13 am IST.

What is the 52 week high and 52 week low of Apimeds Pharmaceuticals US, Inc. stock?

52 week high/low data for Apimeds Pharmaceuticals US, Inc. is currently unavailable.

What is APUS's net income for the last quarter?

APUS's net income for the last quarter is -0.00B USD.

Can I buy APUS shares in India?

Yes. You can buy APUS in India by opening an international trading account.